Literature DB >> 21103994

Bidirectional reprogramming of mouse embryonic stem cell/fibroblast hybrid cells is initiated at the heterokaryon stage.

Maria M Gridina1, Oleg L Serov.   

Abstract

Immunofluorescent analysis of markers specific for parental genomes was used to study heterokaryons and hybrid cells soon after the fusion of diploid embryonic stem (ES) cells marked with green fluorescent protein and diploid fibroblasts labeled by blue fluorescent beads. Heterokaryons were identified by an analysis of parental mitochondrial DNAs. Within 20 h after fusion, most heterokaryons (up to 80%) had a fibroblast-like phenotype, being positive for typical fibroblast markers (collagen type I, fibronectin, lamin A/C) and for the modification me3H3K27 chromatin marking the inactive X chromosome but being negative for Oct4 and Nanog. Approximately 20% of heterokaryons had an alternative ES-like phenotype being positive for Oct4 and Nanog, with signs of reactivation of the previously inactive X-chromosome but negative for fibroblast markers. Hybrid cells having alternative phenotypes were easily identified from 24-48 h. The level of DNA methylation at the promoter of the fibroblast Oct4 allele in the ES-like hybrid cells at day 4 was similar to that of ES cells but at the same time, both parental Oct4 alleles were heavily methylated in fibroblast-like hybrid cells. Thus, bidirectional reprogramming initiated at the heterokaryon stage seems to lead to the formation of two types of hybrid cells with alternative dominance of the parental genomes. However, the further fates of two types of hybrid cells are different: ES-like hybrid cells form colonies at 4-6 days but no colonies are derived from the fibroblast-like hybrid cells. The latter grow as disconnected single cells and are unable to form colonies, like mouse embryonic fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21103994     DOI: 10.1007/s00441-010-1085-2

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  6 in total

1.  Cell divisions are not essential for the direct conversion of fibroblasts into neuronal cells.

Authors:  V S Fishman; T A Shnayder; K E Orishchenko; M Bader; N Alenina; O L Serov
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Oct4 promoter activity in stem cells obtained through somatic reprogramming.

Authors:  Winfried H Krueger; Borko Tanasijevic; Carol Norris; X Cindy Tian; Theodore P Rasmussen
Journal:  Cell Reprogram       Date:  2013-04       Impact factor: 1.987

3.  Allele-Specific Biased Expression of the CNTN6 Gene in iPS Cell-Derived Neurons from a Patient with Intellectual Disability and 3p26.3 Microduplication Involving the CNTN6 Gene.

Authors:  Maria M Gridina; Natalia M Matveeva; Veniamin S Fishman; Aleksei G Menzorov; Helen A Kizilova; Nikolay A Beregovoy; Igor I Kovrigin; Inna E Pristyazhnyuk; Igor P Oscorbin; Maxim L Filipenko; Anna A Kashevarova; Nikolay A Skryabin; Tatyana V Nikitina; Elena A Sazhenova; Ludmila P Nazarenko; Igor N Lebedev; Oleg L Serov
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

4.  Reprogramming somatic cells by fusion with embryonic stem cells does not cause silencing of the Dlk1-Dio3 region in mice.

Authors:  Nariman R Battulin; Anna A Khabarova; Ul'yana A Boyarskikh; Aleksey G Menzorov; Maxim L Filipenko; Oleg L Serov
Journal:  World J Stem Cells       Date:  2012-08-26       Impact factor: 5.326

5.  Comparison of American mink embryonic stem and induced pluripotent stem cell transcriptomes.

Authors:  Aleksei G Menzorov; Natalia M Matveeva; Marios N Markakis; Venyamin S Fishman; Knud Christensen; Anna A Khabarova; Inna E Pristyazhnyuk; Elena A Kizilova; Susanna Cirera; Razvan Anistoroaei; Oleg L Serov
Journal:  BMC Genomics       Date:  2015-12-16       Impact factor: 3.969

6.  Alternative dominance of the parental genomes in hybrid cells generated through the fusion of mouse embryonic stem cells with fibroblasts.

Authors:  Natalia M Matveeva; Veniamin S Fishman; Irina S Zakharova; Alexander I Shevchenko; Inna E Pristyazhnyuk; Aleksei G Menzorov; Oleg L Serov
Journal:  Sci Rep       Date:  2017-12-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.